Autophagy as a molecular target for cancer treatment

被引:283
|
作者
Kocaturk, Nur Mehpare [1 ]
Akkoc, Yunus [2 ]
Kig, Cenk [3 ]
Bayraktar, Oznur [4 ]
Gozuacik, Devrim [1 ,2 ]
Kutlu, Ozlem [1 ]
机构
[1] Sabanci Univ, Nanotechnol Res & Applicat Ctr SUNUM, Orta Mah Univ Cad 27, TR-34956 Istanbul, Turkey
[2] Sabanci Univ, Mol Biol Genet & Bioengn Program, Fac Engn & Nat Sci, TR-34956 Istanbul, Turkey
[3] Istanbul Yeni Yuzyil Univ, Fac Med, TR-34010 Istanbul, Turkey
[4] Okan Univ, Dept Med Biol & Genet, Fac Med, Istanbul, Turkey
关键词
Autophagy; Cancer; Therapeutic agents; ENDOPLASMIC-RETICULUM STRESS; STARVATION-INDUCED AUTOPHAGY; TYROSINE KINASE INHIBITOR; HYPOXIA-INDUCIBLE FACTORS; CELL-DEATH; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; HISTONE DEACETYLASE; MAMMALIAN TARGET; COLON-CANCER;
D O I
10.1016/j.ejps.2019.04.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Autophagy is an evolutionarily conserved catabolic mechanism, by which eukaryotic cells recycle or degrades internal constituents through membrane-trafficking pathway. Thus, autophagy provides the cells with a sustainable source of biomolecules and energy for the maintenance of homeostasis under stressful conditions such as tumor microenvironment. Recent findings revealed a close relationship between autophagy and malignant transformation. However, due to the complex dual role of autophagy in tumor survival or cell death, efforts to develop efficient treatment strategies targeting the autophagy/cancer relation have largely been unsuccessful. Here we review the two-faced role of autophagy in cancer as a tumor suppressor or as a pro-oncogenic mechanism. In this sense, we also review the shared regulatory pathways that play a role in autophagy and malignant transformation. Finally, anti-cancer therapeutic agents used as either inhibitors or inducers of autophagy have been discussed.
引用
收藏
页码:116 / 137
页数:22
相关论文
共 50 条
  • [31] The endothelin axis:: a new molecular "target" for breast cancer treatment
    Wuelfing, P.
    Smollich, M.
    Meyer, V
    Fischgraebe, J.
    Goette, M.
    Kiesel, L.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2007, 67 (04) : 394 - 394
  • [32] Autophagy: a potential target for the treatment of intraocular neovascularization
    Xia-Ru Zhu
    Jun-Hui Du
    International Journal of Ophthalmology, 2018, (04) : 695 - 698
  • [33] Emerging molecular target antagonists for the treatment of biliary tract cancer
    Lombardi, Pasquale
    Marino, Donatella
    Fenocchio, Elisabetta
    Chila, Giovanna
    Aglietta, Massimo
    Leone, Francesco
    EXPERT OPINION ON EMERGING DRUGS, 2018, 23 (01) : 63 - 75
  • [34] RICTOR amplification as a novel molecular target for the treatment of lung cancer
    Cheng, H.
    Piperdi, B.
    Zou, Y.
    Verma, A.
    Liu, X.
    Schwartz, E.
    Zhu, C.
    Montagna, C.
    Halmos, B.
    Chachoua, A.
    Perez-Soler, R.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 108 - 109
  • [35] Stathmin is a potential molecular marker and target for the treatment of gastric cancer
    Liu, Xiaolin
    Liu, Hairong
    Liang, Jing
    Yin, Beibei
    Xiao, Junjuan
    Li, Junwei
    Feng, Dongfeng
    Li, Yan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (04): : 6502 - 6509
  • [36] Autophagy in Cervical Cancer: An Emerging Therapeutic Target
    Pandey, Saumya
    Chandravati
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (10) : 4867 - 4871
  • [37] Emerging strategies to effectively target autophagy in cancer
    Rebecca, V. W.
    Amaravadi, R. K.
    ONCOGENE, 2016, 35 (01) : 1 - 11
  • [38] Emerging strategies to effectively target autophagy in cancer
    V W Rebecca
    R K Amaravadi
    Oncogene, 2016, 35 : 1 - 11
  • [39] Mitochondria autophagy: a potential target for cancer therapy
    Qiu, Yu-Han
    Zhang, Tian-Shu
    Wang, Xiao-Wei
    Wang, Meng-yan
    Zhao, Wen-Xia
    Zhou, Hui-Min
    Zhang, Cong-Hui
    Cai, Mei-Lian
    Chen, Xiao-Fang
    Zhao, Wu-Li
    Shao, Rong-Guang
    JOURNAL OF DRUG TARGETING, 2021, 29 (06) : 576 - 591
  • [40] Autophagy: A potential target for thyroid cancer therapy
    Yi, Heqing
    Long, Bin
    Ye, Xuemei
    Zhang, Lijun
    Liu, Xiaodong
    Zhang, Chunyan
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (05) : 661 - 665